RepSox effectively promotes the induced differentiation of sheep fibroblasts into adipocytes via the inhibition of the TGF‑β1/Smad pathway

Int J Mol Med. 2021 Aug;48(2):148. doi: 10.3892/ijmm.2021.4981. Epub 2021 Jun 16.

Abstract

Previous reports have demonstrated that RepSox can function as a replacement for cMyc and Sox2 in the reprogramming of cells into induced pluripotent stem cells (iPSCs), as well as increasing the levels of bone morphogenetic protein (BMP)‑3 and inducing the phosphorylation of Smad1 in mouse embryonic stem cells. In the present study, it was demonstrated that RepSox caused the visible morphological transformation of sheep fibroblasts; however, no significant alterations in cell proliferation, apoptosis or chromosome aberrations were observed. Moreover, RepSox increased the plasticity of long‑term cryopreserved sheep fibroblasts, and further promoted differentiation into adipocytes. RepSox treatment led to a notable decrease in the expression of components of the transforming growth factor (TGF)‑β signaling pathway, particularly Smad2/3 phosphorylation. RepSox also activated the BMP pathway, promoted the reprogramming of cells from fibroblasts into adipocytes and induced mesenchymal‑epithelial transition. It is worth noting that RepSox notably increased the expression of octamer‑binding transcription factor 4 and L‑Myc, whereas Sox2 and Nanog expression were not detected. The results of high‑throughput RNA sequencing revealed that the levels of differentially expressed genes (DEGs) involved in various metabolic processes were markedly upregulated in the RepSox‑treated fibroblasts, while the DEGs in the majority of signaling pathways were markedly downregulated. On the whole, the present study demonstrates that RepSox can promote the plasticity of sheep fibroblasts and facilitates the differentiation of adipocytes via increasing BMP expression and inhibiting the activation of the TGF‑β signaling pathway.

Keywords: RepSox; adipogenic differentiation; fibroblasts; octamer‑binding transcription factor 4; transforming growth factor‑β/Smad.

MeSH terms

  • Adipocytes / cytology
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Bone Morphogenetic Protein 4 / genetics
  • Bone Morphogenetic Protein 4 / metabolism
  • Bone Morphogenetic Protein Receptors, Type I / genetics
  • Bone Morphogenetic Protein Receptors, Type I / metabolism
  • Cell Differentiation / drug effects*
  • Cell Differentiation / genetics
  • Cell Proliferation / drug effects
  • Cell Proliferation / genetics
  • Cells, Cultured
  • Fibroblasts / cytology
  • Fibroblasts / drug effects*
  • Fibroblasts / metabolism
  • Gene Expression / drug effects
  • Male
  • Phosphorylation / drug effects
  • Pyrazoles / pharmacology*
  • Pyridines / pharmacology*
  • RNA-Seq / methods
  • Sheep
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Smad Proteins / genetics
  • Smad Proteins / metabolism*
  • Transforming Growth Factor beta1 / genetics
  • Transforming Growth Factor beta1 / metabolism*

Substances

  • Bone Morphogenetic Protein 4
  • Pyrazoles
  • Pyridines
  • RepSox
  • Smad Proteins
  • Transforming Growth Factor beta1
  • Bone Morphogenetic Protein Receptors, Type I

Grants and funding

The present study was supported by the National Natural Science Foundation of China (grant no. 81771381), the project National Infrastructure of Animal Germplasm Resources (year of 2019), Anhui Provincial Natural Science Foundation (grant no. 1908085MH277), and the Natural Science Foundation of the Higher Education Institutions of Anhui Province (grant nos. KJ2017A215 and KJ2019A0322), and the Undergraduate Innovative Training Program of China (grant nos. 201910367005 and 201910367039).